Earnings Feed
Start Free
Amneal Pharmaceuticals, Inc.·4

Mar 7, 5:41 PM ET

TERRERI PETER R 4

4 · Amneal Pharmaceuticals, Inc. · Filed Mar 7, 2019

Insider Transaction Report

Form 4
Period: 2019-03-06
Amneal Pharmaceuticals, Inc.AMRX
TERRERI PETER R
Director
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2019-03-06$6.55/sh+45,000$294,750→ 70,192 total
  • Sale

    Class A Common Stock

    2019-03-06$12.39/sh−23,345$289,245→ 25,192 total
  • Exercise/Conversion

    Stock Option

    2019-03-06−45,000→ 0 total
    Exercise: $6.55Exp: 2019-05-20→ Class A Common Stock (45,000 underlying)
Footnotes (2)
  • [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.39 per share to $12.38 per share. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The option is vested and currently exercisable.

Documents

2 files